News - Latest

98 news items

Enter search criteria

Fill in keyword(s) to narrow your search.

Periode

Enter a start and/or end date here, using the following format: DD-MM-YYYY.

Subscribe to latest news

The MEB is preparing for Brexit

The United Kingdom has decided to leave the European Union. This has consequences for the regulation of medicines in Europe. The ...

News item | 26-10-2017 | 12:00

EudraVigilance Veterinary not available for 10 days starting 8 November 2017

The new EudraVigilance system for the reporting and analysis of suspected adverse reactions (ADRs) to medicinal products, will ...

News item | 16-10-2017 | 10:00

Safety features protect consumers against falsified medicines

From 9 February 2019 onwards, the packaging of prescription-only medicinal products must have safety features to protect ...

News item | 05-10-2017 | 14:00

EudraVigilance not available for 10 days starting 8 November 2017

The new EudraVigilance system for the reporting and analysis of suspected adverse reactions (ADRs) to medicinal products, will ...

News item | 04-10-2017 | 15:00

Last call for marketing authorisation holders to submit information about in-use shelf life of OTC medicinal products

Marketing authorisation holders are obliged to include information about the in-use shelf-life of OTC medicinal products in the ...

News item | 13-09-2017 | 10:00

The Dutch bid for the European Medicines Agency

Commitment, continuity, connectivity and community – those are the keywords in the Dutch bid for the EMA.

News item | 11-07-2017 | 13:00

2nd Edition of MEB Regulatory Science Magazine released

Today, the 2nd edition of the Regulatory Science Magazine was released. This online magazine, produced by the Medicines ...

News item | 15-06-2017 | 16:00

Assessment criteria for combination packages policy established

The Medicines Evaluation Board (MEB) has described the terms and conditions which are to be used to assess applications for ...

News item | 15-06-2017 | 15:00

New legal EudraVigilance obligations as of 22 November 2017

As of 22 November 2017 new obligations in respect of signal management and reporting of suspected adverse reactions (ADRs) will ...

News item | 06-06-2017 | 13:00

Eric Boersma sworn in as new MEB Member

Mr Prof H. (Eric) Boersma was sworn in as a new member of the Medicines Evaluation Board (MEB) on 1 June 2017.

News item | 02-06-2017 | 10:00